Hannah Kinoshita

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Venues

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal A Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick J Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
ANHL1522: Durable Immunity to EBV post Rituximab and Third Party LMP-specific T-cells: A Children's Oncology Group Study. Blood advances (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal A Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick J Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
ANHL1522: Durable Immunity to EBV post Rituximab and Third Party LMP-specific T-cells: A Children's Oncology Group Study. Blood advances (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood advances 8 (5) (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood advances 8 (5) (2024)
Birte Wistinghausen, Keri Toner, Donald A Barkauskas, Lauren P Jerkins, Hannah Kinoshita, Pamela A Chansky, Gloria Pezzella, Lauren Saguilig, Robert J Hayashi, Harshal Abhyankar, Brooks Scull, Vivekanudeep Karri, Jay Tanna, Patrick Hanley, Michelle L Hermiston, Carl E Allen, Catherine M Bollard
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood advances 8 (5) (2024)
Hannah Kinoshita, Kenneth R Cooke, Melanie L Grant, Maja Stanojevic, C Russell Cruz, Michael Keller, Maria Fernanda Fortiz, Fahmida Hoq, Haili Lang, A John Barrett, Hua Liang, Jay Tanna, Nan Zhang, Abeer Shibli, Anushree Datar, Kenneth Fulton, Divyesh Kukadiya, Anqing Zhang, Kirsten M Williams, Hema Dave, Jeffrey S Dome, David Jacobsohn, Patrick J Hanley, Richard J Jones, Catherine M Bollard
Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT. Blood advances 6 (8) (2022)
Hannah Kinoshita, Mamatha Mandava, Mariah A Jensen-Wachspress, Haili Lang, Elisabeth Joy, Jay Tanna, Chase D McCann, Samuel O'Brien, Sianna Burnett, Abeer Shibli, Fahmida Hoq, Monica Bhatia, Patrick J Hanley, Blachy J Dávila Saldaña, Kris M Mahadeo, Catherine M Bollard, Michael D Keller, Allistair A Abraham
Outcomes following posttransplant viral-specific T-cell therapy in patients with sickle cell disease. Blood advances (2022)

Hannah Kinoshita.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hannah Kinoshita